NCT06822205 Identification and Treatment of Renal Stenosis in Transplanted Kidneys
| NCT ID | NCT06822205 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Renal Artery Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-07-07 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-07-07 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Renal artery stenosis is a complication that may follow kidney transplantation1-5. Renal artery stenosis greater than 50% of the lumen of the artery, associated with clinical symptoms or laboratory worsening of renal function, may lead to transplant failure, however, the indications for treatment and the modalities of treatment remain, to date, a debated topic in the literature. The guidelines of the European Society of Urology recommend endovascular treatment as the first-line treatment by means of angioplasty and/or stent placement6. A recent review of the literature7 examined the results of 56 studies: the results fully support endovascular treatment of the disease which appears to be effective and with a low rate of complications.
Eligibility Criteria
Inclusion Criteria: * Age greater than or equal to 18 years * Indication of renal transplant and diagnosis of renal artery stenosis of the transplant * Obtaining informed consent Exclusion Criteria: \-
Contact & Investigator
Mauro Gargiulo, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06822205 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Renal Artery Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06822205 currently recruiting?
Yes, NCT06822205 is actively recruiting participants. Contact the research team at mauro.gargiulo2@unibo.it for enrollment information.
Where is the NCT06822205 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06822205 clinical trial?
NCT06822205 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Mauro Gargiulo, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 30 participants.